Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients
Recruitment status was Recruiting
TITLE: Anti-Ischemic effects of Abciximab(Reopro)
PATIENT POPULATION: Patients undergoing PCI(an interventional procedure placing a small stent/metallic tube to keep a narrowed artery in your heart open) and either on a stable statin dose or not on a statin. Statin= cholesterol lowering drug(ie, lipitor, zocor).
INTERVENTION: Heparin vs. heparin + abciximab during PCI
PURPOSE: Measure the effects of abciximab on special healing blood stem cells (EPC's-Endothelial Progenitor Cells), on inflammation, on oxidative stress and on microvascular blood flow.
- 50ccs blood draw on day 1(from sheath), day 2 ,day 7 and day 28.
- Measurement of blood flow in selected suitable patients
- 10 minute questionnaire before discharge and on visit on day 28.
|Study Design:||Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
|Contact: Tanuj K Kamineni||404 712 email@example.com|
|Contact: Johnson Pereira, MD||404 712 firstname.lastname@example.org|
|United States, Georgia|
|Emory University Hospital||Recruiting|
|Atlanta, Georgia, United States, 30322|
|Contact: Tanuj K Kamineni 404-712-0168 email@example.com|
|Contact: Johnson Pereira, MD 404-712-0168 firstname.lastname@example.org|
|Atlanta VA Medical Center||Recruiting|
|Atlanta, Georgia, United States, 30033|
|Contact: Kreton Mavromatis, MD 404-329-2207 email@example.com|
|Contact: Padi K Reddy 4043216111 ext 6223|
|Principal Investigator:||Arshed A Quyyumi, M.D.||EUH|